Tizona Therapeutics, Inc., is a privately held immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune disorders. Tizona's therapies are designed to regulate suppressive cells, thereby either activating the body's ability to fight cancer or preventing the immune system from attacking healthy tissues in autoimmune diseases.
Market
Cancer and autoimmune disorders
Location
South San Francisco,
California,
USA
Coinvestors
Abingworth, Amgen Business Development, Astellas Venture Management, Canaan Partners, InterWest Partners, Lightstone Ventures, MPM Capital